Clinical variability in a Noonan syndrome family with a new PTPN11 gene mutation

被引:33
作者
Bertola, DR
Pereira, AC
de Oliveira, PSL
Kim, CA
Krieger, JE
机构
[1] Univ Sao Paulo, Hosp Clin, Inst Crianca, Clin Genet Unit, BR-05508 Sao Paulo, Brazil
[2] Univ Sao Paulo, Inst Heart, InCor, Lab Genet & Cardiol Mol, BR-05508 Sao Paulo, Brazil
[3] Univ Sao Paulo, Sch Med, Disciplina Informat Med, BR-05508 Sao Paulo, Brazil
关键词
PTPN11; autosomal dominant disorder; Noonan syndrome;
D O I
10.1002/ajmg.a.30270
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
syndrome (NS) is an autosomal dominant disorder comprising short stature, facial dysmorphism, short and/or webbed neck, heart defects, and cryptorchidism in males. The gene responsible for the disorder (PTPN11) was recently identified, and explains 30-50% of the cases clinically diagnosed as NS. Cardiofaciocutaneous (CFC) syndrome, a similar but distinct entity, is characterized by relative macrocephaly, characteristic facial appearance, ectodermal abnormalities (sparse and friable hair, sparse eyebrows, hyperkeratotic skin), congenital heart defects, and growth and mental retardation. We describe on a young woman who presents clinical features of NS (short stature, triangular facies, with dowslanting palpebral fissures and apparent hypertelorism, webbed neck, pulmonary stenosis, bleeding diathesis, prominent corneal nerves), but with a more prominent ectodermal involvement (sparse and very coarse hair, sparse eyebrows and eyelashes) and developmental delay/mental retardation, which are characteristic of CFC patients. Sequencing of the PTPN11 gene showed a T411M substitution, not previously described in patients with NS. The same mutation was found in her mother and older sister, not initially considered to be affected by NS, but with very subtle clinical findings compatible with this diagnosis. Molecular dynamic studies indicate that this new mutation, similar to other previously described mutations, favors a more active protein conformation. However, the main disruptive effect is not directly in the catalytic domain, suggesting that the location of this mutation could make the protein more susceptible to gene-gene or gene-environment interactions. Atypical cases of NS should be screened for mutations in the PTPN11 gene and in the case of a positive result, first-degree relatives should also be tested for the specific mutation. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:378 / 383
页数:6
相关论文
共 45 条
[1]   NOONAN SYNDROME [J].
ALLANSON, JE .
JOURNAL OF MEDICAL GENETICS, 1987, 24 (01) :9-13
[2]   NOONAN SYNDROME - THE CHANGING PHENOTYPE [J].
ALLANSON, JE ;
HALL, JG ;
HUGHES, HE ;
PREUS, M ;
WITT, RD .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1985, 21 (03) :507-514
[3]  
Bertola D R, 1999, Rev Hosp Clin Fac Med Sao Paulo, V54, P147
[4]   NOONAN SYNDROME - REVIEW OF CLINICAL AND GENETIC FEATURES OF 27 CASES [J].
COLLINS, E ;
TURNER, G .
JOURNAL OF PEDIATRICS, 1973, 83 (06) :941-950
[5]   Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene [J].
Digilio, MC ;
Conti, E ;
Sarkozy, A ;
Mingarelli, R ;
Dottorini, T ;
Marino, B ;
Pizzuti, A ;
Dallapiccola, B .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (02) :389-394
[6]   A COMPREHENSIVE SCORING SYSTEM FOR EVALUATING NOONAN SYNDROME [J].
DUNCAN, WJ ;
FOWLER, RS ;
FARKAS, LG ;
ROSS, RB ;
WRIGHT, AW ;
BLOOM, KR ;
HUOT, DJ ;
SONDHEIMER, HM ;
ROWE, RD .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1981, 10 (01) :37-50
[7]   THE CARDIO-FACIO-CUTANEOUS (CFC) SYNDROME AND NOONAN SYNDROME - ARE THEY THE SAME [J].
FRYER, AE ;
HOLT, PJ ;
HUGHES, HE .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1991, 38 (04) :548-551
[8]  
FRYNS J P, 1992, Genetic Counseling, V3, P19
[9]  
Grebe TA, 2000, AM J MED GENET, V95, P135, DOI 10.1002/1096-8628(20001113)95:2<135::AID-AJMG8>3.0.CO
[10]  
2-J